Endoscopic ultrasound in pancreatic cancer treatment: Facts and hopes - 29/09/19
, Rodrigo Liberal, Guilherme MacedoBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 9 |
| Iconographies | 1 |
| Vidéos | 0 |
| Autres | 0 |
Summary |
Pancreatic ductal adenocarcinoma is one of the most common causes of cancer-related deaths. Since most patients present with advanced disease, its prognosis is dismal. New and more effective therapeutic strategies are needed. Endoscopic ultrasound is currently an indispensable tool for the diagnosis and staging of pancreatic ductal adenocarcinoma. In recent years, endoscopic ultrasound has evolved to become also a therapeutic procedure. On one hand, the role of endoscopic ultrasound in the management of pancreatic cancer-related symptoms (pain, obstructive jaundice, and gastric outlet obstruction) is now well established. On the other hand, its use as a mean to the delivery of anti-tumor therapies (injecting anti-tumor agents, assisting in radiotherapy, and guiding ablative therapies) is still mostly experimental, despite growing evidence supporting its feasibility, safety and efficacy.
Le texte complet de cet article est disponible en PDF.Plan
Vol 43 - N° 5
P. 513-521 - octobre 2019 Retour au numéro
Article précédent
- Domino liver transplantation: the risk of disease recurrence
- Filoména Conti, Fanny Mochel, Yvon Calmus
- On hepatocellular carcinoma in South America and early-age onset of the disease
- Pascal Pineau, Eloy Ruiz, Eric Deharo, Stéphane Bertani
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?